Citation 160966

HALL,IH: TAGAHARA,K: LEE,KH:. (1982). ANTITUMOR AGENTS 53: THE EFFECTS OF DAPHNORETIN ON NUCLEIC ACID AND PROTEIN SYNTHESIS OF EHRLICH ASCITES TUMOR CELLS.. 71()

Citation Details

Title	ANTITUMOR AGENTS 53: THE EFFECTS OF DAPHNORETIN ON NUCLEIC ACID AND PROTEIN SYNTHESIS OF EHRLICH ASCITES TUMOR CELLS.
Authors	HALL,IH: TAGAHARA,K: LEE,KH:
Year	1982
Volume	71
Issue

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (1)

Wikstroemia indica (THYMELAEACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA POLYMERASE INHIBITION	PRESENT IN (REVIEW)PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
2	M-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
3	R-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
4	T-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
5	RIBONUCLEOTIDE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
6	FORMIC ACID INCORPORATION INTO PURINES INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
7	PHOSPHORIBOSYL PYROPHOSPHATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
8	INOSINIC ACID DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
9	DIHYDROFOLATE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
10	CARBAMYL PHOSPHATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
11	ASPARTATE CARBAMATE TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
12	OROTIDINE-5'-PHOSPHATE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
13	THYMIDYLATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
14	THYMIDINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
15	THYMIDYLATE MONOPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
16	THYMIDYLATE DIPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
17	ACID DEOXYRIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
18	ACID RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
19	ACID CATHEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	INACTIVE
20	PHOSPHORYLATION OF NONHISTONE PROTEIN STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
21	SUCCINATE DEHYDROGENASE INHIBITION(STATE 4)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
22	SUCCINATE DEHYDROGENASE INHIBITION(STATE 3)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
23	ALPHA-KETOGLUTARATE DEHYDROGENASE INHIBITION(STATE 4)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
24	ALPHA-KETOGLUTARATE DEHYDROGENASE INHIBITION(STATE 3)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAPHNORETIN	ACTIVE
25	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNORETIN	ACTIVE
26	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNORETIN	ACTIVE
27	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAPHNORETIN	ACTIVE
28	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
29	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
30	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
31	DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
32	M-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
33	R-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
34	T-RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
35	RIBONUCLEOTIDE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
36	FORMIC ACID INCORPORATION INTO PURINES INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
37	PHOSPHORIBOSYL PYROPHOSPHATE AMINOTRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
38	INOSINIC ACID DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
39	DIHYDROFOLATE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
40	CARBAMYL PHOSPHATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	INACTIVE
41	ASPARTATE CARBAMATE TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
42	OROTIDINE-5'-PHOSPHATE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
43	THYMIDYLATE SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
44	THYMIDINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
45	THYMIDYLATE MONOPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
46	THYMIDYLATE DIPHOSPHATE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
47	PHOSPHORYLATION OF HISTONE PROTEIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
48	PHOSPHORYLATION OF NONHISTONE PROTEIN STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	ACTIVE
49	ACID RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAPHNORETIN	INACTIVE

Citation 160966

Citation Details

Summary

Organisms and Their Experiments (1)

Wikstroemia indica (THYMELAEACEAE)

Show SPARQL Queries (1)

Query 1